Catalyst Wire Dossier Catalyst Wire Dossier

Elpipodect (MK-8189)

MK-8189 · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Elpipodect (MK-8189), covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Elpipodect (MK-8189) Human Absorption, Metabolism, and Excretion in Healthy Male Participants (MK-8189-010) [Phase 1]

See pricing